Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015826
Filing Date
2024-06-06
Accepted
2024-06-06 17:54:34
Documents
1
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 form4-06062024_090630.html 4  
1 form4-06062024_090630.xml 4 4099
  Complete submission text file 0001415889-24-015826.txt   5671
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 241026632

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)